Outlook Therapeutics, Inc. - COM NEW (OTLK)

Historical Portfolio Holders from Q1 2019 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
316 K
Holdings value Q1 2024
$3.73 M
Value change Q1 2024
-$7.94 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
3
Number of buys Q1 2024
1
Number of sells Q1 2024
-2
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
0%
CUSIP
69012T206
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 450 K $3.32 M +$1.02 M $7.38 1
2024 Q1 316 K $3.73 M -$7.94 M $10.60 3
2023 Q4 29.5 M $11.6 M +$925 K $0.39 84
2023 Q3 27.3 M $6.03 M -$5.34 M $0.22 76
2023 Q2 29.2 M $50.7 M +$3.69 M $1.74 84
2023 Q1 27.2 M $29.7 M -$199 K $1.09 79
2022 Q4 27.4 M $29.6 M +$3.58 M $1.08 75
2022 Q3 24 M $29.3 M -$932 K $1.22 73
2022 Q2 24.7 M $25.2 M -$947 K $1.02 69
2022 Q1 25.3 M $45.3 M +$2.82 M $1.78 69
2021 Q4 23.9 M $32.5 M +$3.67 M $1.36 67
2021 Q3 21.1 M $46 M +$1.83 M $2.17 61
2021 Q2 20.2 M $50.2 M +$17.5 M $2.49 59
2021 Q1 13.4 M $30.2 M +$16.9 M $2.25 48
2020 Q4 5.94 M $7.73 M +$2.85 M $1.30 28
2020 Q3 3.85 M $2.77 M +$1.52 M $0.72 25
2020 Q2 1.68 M $2.17 M -$2.29 M $1.30 18
2020 Q1 5.93 M $3.57 M +$2.74 M $0.60 16
2019 Q4 1.44 M $847 K +$220 K $0.59 12
2019 Q3 943 K $1.41 M +$142 K $1.49 13
2019 Q2 828 K $1.72 M +$1.33 M $2.07 11
2019 Q1 121 K $896 K +$896 K $7.40 11